Cargando…
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
Lack or dysfunction of the lymphatics leads to secondary lymphedema formation that seriously reduces the function of the affected organs and results in degradation of quality of life. Currently, there is no definitive treatment option for lymphedema. Here, we utilized nucleoside-modified mRNA encaps...
Autores principales: | Szőke, Dániel, Kovács, Gábor, Kemecsei, Éva, Bálint, László, Szoták-Ajtay, Kitti, Aradi, Petra, Styevkóné Dinnyés, Andrea, Mui, Barbara L., Tam, Ying K., Madden, Thomas D., Karikó, Katalin, Kataru, Raghu P., Hope, Michael J., Weissman, Drew, Mehrara, Babak J., Pardi, Norbert, Jakus, Zoltán |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187400/ https://www.ncbi.nlm.nih.gov/pubmed/34103491 http://dx.doi.org/10.1038/s41467-021-23546-6 |
Ejemplares similares
-
Inflammatory Manifestations of Lymphedema
por: Ly, Catherine L., et al.
Publicado: (2017) -
Reduced Prenatal Pulmonary Lymphatic Function Is Observed in Clp1(K/K) Embryos With Impaired Motor Functions Including Fetal Breathing Movements in Preparation of the Developing Lung for Inflation at Birth
por: Szoták-Ajtay, Kitti, et al.
Publicado: (2020) -
Histopathologic Features of Lymphedema: A Molecular Review
por: Li, Claire Y., et al.
Publicado: (2020) -
Abstract 120: Lymph Node Transplantation Decreases Local Immunosuppression In Lymphedema
por: Ly, Catherine L., et al.
Publicado: (2018) -
20. Skin Barrier Dysfunction in Lymphedema
por: Campbell, Adana, et al.
Publicado: (2023)